Cellexus Biosystems reports the Granting of Fundamental Technology UK Patent
The Board of Cellexus Biosystems plc announced that the Company has been issued with the British patent GB2433216 covering the core technology for the CellMaker family of disposable bioreactor and fermentor products.
Commenting on this granting by the UK Patent Office, the inventor of the CellMaker technology, Dr Kevin Auton, commented: "The grant of this first patent for the Cellexus technology is an important milestone for Cellexus Biosystems as it provides us with the protection we require to exploit our position in cell culture and fermentation and validates the novelty of our single-use bioreactor and fermentors. We now routinely demonstrate that the CellMaker technology is as effective as a traditional stirred bioreactor, even for fermentation, which requires high rates of oxygen transfer. High mass transfer of oxygen is achieved without moving parts and is a result of the unique bioreactor geometry. This patent will be filed in all major markets and has already been filed in the US".
Other news from the department research and development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
RNA: a vicious pathway to cancer?

Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences

Peptide complex formed in the brain is responsible for Alzheimer's disease
Innovacell Includes First Patients in a Phase IIb Study for Its Cell Therapy Product urocell
Cocaine addiction: Scientists discover 'back door' into the brain
List_of_human_anatomical_parts_named_after_people

Berkeley Researchers Identify Photosynthetic Dimmer Switch
Rentschler Expands Single-Use Manufacturing Capacities
Modeling NAFLD with human pluripotent stem cell derived immature hepatocyte like cells
